Recent advances have greatly improved our understanding of the molecular mechanisms
behind atherosclerosis pathogenesis. However, there is still a need to systematize this data …

Cardiovascular disease (CVD) is still a leading cause of morbidity and mortality, despite all
the progress achieved as regards to both prevention and treatment. Having high levels of …

Background The risk of cardiovascular disease (CVD) depended on the magnitude and
exposure duration of insulin resistance (IR). This study aimed to investigate the associations …

A steady rise in cardiovascular morbidity and mortality has been observed in young adults
within the last decades. This trend corresponds to an increasing prevalence of traditional …

Personalized nutrition (PN) has gained much attention as a tool for empowerment of
consumers to promote changes in dietary behavior, optimizing health status and preventing …

Evidence suggests that inflammation plays an important role in atherosclerosis and the
consequent clinical presentation, including stable coronary artery disease (CAD) and acute …

Simple Summary Glycolipid metabolic disorders (GLMDs) result from imbalances in
glycolipid levels, leading to various health issues, including obesity, diabetes, liver …

Lipoprotein (a)[Lp (a)] consists of a low-density lipoprotein-like molecule and an
apolipoprotein (a)[apo (a)] particle. Lp (a) has been suggested to be an independent risk …

Cardiovascular diseases (CVDs) are the leading cause of death globally, attributed to a
complex etiology involving metabolic, genetic, and protein-related factors. Lipoprotein (a)(Lp …

Lipoprotein (a) is a low-density-lipoprotein-like particle that consists of apolipoprotein (a)
bound to apolipoprotein (b). It has emerged as an established causal risk factor for …